Navigation Links
USC scientist's revolutionary drug pump draws NSF support
Date:11/2/2011

Last month, for the first time in 11 years, USC Associate Professor Ellis Meng found herself raising her hand and asking questions in the classroom not answering them.

Meng, whose research at USC focuses on developing a tiny, implantable medication-delivery system, is enrolled in a business crash-course sponsored by the National Science Foundation, learning how to understand customers, develop viable business models, and get on the fast track to becoming a commercial product.

She was selected to receive the NSF's new Innovation Corps award. The award is designed to help researchers get innovative ideas out of the lab and into the real world.

"It's supposed to kick-start the effort," said Meng, who teaches biomedical and electrical engineering at the USC Viterbi School of Engineering.

A couple weeks ago, she and her team flew to Stanford University to attend a three-day business bootcamp.

"We were sort of fed through the firehose," Meng said. Now back in Los Angeles, she is continuing her education online. In December, Meng's team and 20 others that have been selected by the NSF will pitch their products and newly developed business strategies for marketing them to a room full of potential investors.

Meng's team was among the NSF's first cohort to receive the six-month, $50,000 award.

Each team includes a principle investigator, a student or post doc, and an industry mentor. Meng is working with Christian Gutierrez, a recent Viterbi PhD graduate; Tuan Hoang, a Viterbi lecturer; and Carol Christopher, an industry expert and mentor.

She joked that the program is designed to "help you fail quickly" that is, to spend a minimum of time and resources figuring out whether a product being developed by a researcher has a potential to succeed commercially in a specific market, or whether it needs to be applied to a different market or reimagined.

The course has already offered useful insights into Meng's drug delivery pump, which is designed to address chronic conditions that require long term, localized use of drugs such as cancer, epilepsy, and chronic pain.

Because of its tiny size smaller in diameter than a dime, and as thick as a short stack of quarters the pump can also be used in animal studies, unlike older designs.

Currently, similar pumps are bulky, which makes them difficult to implant inconspicuously, particularly in children. Meng's pump enjoys a much better volume efficiency, meaning that the bulk of the device is taken up by the medication it delivers, as opposed to complicated mechanical pumps or batteries.

Part of that is due to the fact that the pump does not require large batteries it is the first drug pump that can be powered up and operated wirelessly. With the I-Corps award, Meng hopes to see her invention realized as a commercial product soon.

"The timing was perfect," she said. "I'm happy that the NSF is so forward thinking and pioneered a program like this. Through this effort, we can work together to make sure technologies are not orphaned in the laboratory."


'/>"/>

Contact: Robert Perkins
perkinsr@usc.edu
213-740-9226
University of Southern California
Source:Eurekalert

Related biology news :

1. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
2. Scientists identify novel inhibitor of human microRNA
3. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
4. MU scientists go green with gold, distribute environmentally friendly nanoparticles
5. Scientists identify gene that may contribute to improved rice yield
6. Scientists discover why a mothers high-fat diet contributes to obesity in her children
7. MU scientists see how HIV matures into an infection
8. Earth scientists keep an eye on Texas
9. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
10. Scientists identify a molecule that coordinates the movement of cells
11. Scientists Find new migratory patterns for Mediterranean and Western Atlantic bluefin tuna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: